Compare CRL & PPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRL | PPC |
|---|---|---|
| Founded | 1947 | 1946 |
| Country | United States | United States |
| Employees | N/A | 52100 |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Meat/Poultry/Fish |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 9.7B |
| IPO Year | 1999 | 1997 |
| Metric | CRL | PPC |
|---|---|---|
| Price | $169.09 | $38.84 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 3 |
| Target Price | ★ $197.58 | $44.33 |
| AVG Volume (30 Days) | ★ 1.3M | 839.1K |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | N/A | ★ 20.61% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 4.54 |
| Revenue | $1,857,601,000.00 | ★ $18,497,553,000.00 |
| Revenue This Year | $2.11 | $2.39 |
| Revenue Next Year | $2.95 | $1.82 |
| P/E Ratio | ★ N/A | $8.97 |
| Revenue Growth | ★ 10.48 | 3.46 |
| 52 Week Low | $91.86 | $35.73 |
| 52 Week High | $228.88 | $56.73 |
| Indicator | CRL | PPC |
|---|---|---|
| Relative Strength Index (RSI) | 39.71 | 33.57 |
| Support Level | $166.86 | $36.80 |
| Resistance Level | $182.81 | $38.86 |
| Average True Range (ATR) | 7.69 | 1.10 |
| MACD | 1.71 | -0.41 |
| Stochastic Oscillator | 54.40 | 0.00 |
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Pilgrim's Pride is the second-largest poultry producer in the US (59% of 2024 sales), the UK (29% including other European sales), and Mexico (12%). Its UK and European arm also includes pork operations from the 2019 acquisition of Tulip. Pilgrim's sells to chain restaurants, food processors, food distributors, and retail chains. Most of its US and Mexican sales come from fresh chicken, while prepared chicken and pork constitute most of its UK and European sales. JBS owns more than 80% of Pilgrim's Pride's outstanding shares, though it failed to acquire the remaining stake in 2021 after a special board committee deemed JBS's offer undervalued Pilgrim's Pride.